White blood cells of two children suffering from adenosine deaminase deficiency (ADA-SCID) were genetically modified ex vivo to express a functional version of the gene for making adenosine deaminase, and transferred back into the patients. This evidence concerns the gene ADA and severe combined immunodeficiency.